Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Tham

Showing results (121-130 of 127) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 127 results.
Gastrointestinal Endoscopy|October 25, 2002
Risk factors for complications after performance of ERCPJo Vandervoort, Roy M Soetikno, Tony C K Tham, et al.
British Journal of Cancer|September 24, 2014
Dose escalation to rash for erlotinib plus gemcitabine for metastatic pancreatic cancer: the phase II RACHEL studyE Van Cutsem, C-P Li, E Nowara, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 4, 2017
A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC)W M Tai, W P Yong, C Lim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2016
A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC)W M Tai, W P Yong, C Lim, et al.
The American Journal of Gastroenterology|April 15, 2015
BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade DysplasiaCathy Bennett, Paul Moayyedi, Douglas A Corley, et al.
The American Journal of Gastroenterology|June 9, 2015
Addendum: BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade DysplasiaCathy Bennett, Paul Moayyedi, Douglas A Corley, et al.
Gastroenterology|April 28, 2012
Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi processCathy Bennett, Nimish Vakil, Jacques Bergman, et al.
Pageof 13

Showing results (121-130 of 127) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 127 results.
Gastrointestinal Endoscopy|October 25, 2002
Risk factors for complications after performance of ERCPJo Vandervoort, Roy M Soetikno, Tony C K Tham, et al.
British Journal of Cancer|September 24, 2014
Dose escalation to rash for erlotinib plus gemcitabine for metastatic pancreatic cancer: the phase II RACHEL studyE Van Cutsem, C-P Li, E Nowara, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 4, 2017
A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC)W M Tai, W P Yong, C Lim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2016
A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC)W M Tai, W P Yong, C Lim, et al.
The American Journal of Gastroenterology|April 15, 2015
BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade DysplasiaCathy Bennett, Paul Moayyedi, Douglas A Corley, et al.
The American Journal of Gastroenterology|June 9, 2015
Addendum: BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade DysplasiaCathy Bennett, Paul Moayyedi, Douglas A Corley, et al.
Gastroenterology|April 28, 2012
Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi processCathy Bennett, Nimish Vakil, Jacques Bergman, et al.
Pageof 13